Key result
Recent progress in genetic studies of multiple sclerosis has identified a growing list of genetic risk factors, with hopes of translating this knowledge into personalized treatment options.
A review of the progress in genetic studies of multiple sclerosis and the potential for personalized treatment.
Multiple sclerosis (MS) is an inflammatory, demyelinating heterogeneous disease of the central nervous system, probably caused by an interaction of common genetic and environmental factors. Much progress has been made through the last few years in genetic studies of MS, and a growing list of genetic risk factors is now available. Biobanking and large collaborations have been prerequisites for this research, and detailed genetic and molecular characterizations are underway, with hopes for to translating new knowledge about MS pathogenesis and characteristics of the disease to personalized, better treatment options for each patient with MS.
No takes yet. Share an insight, caveat, or question.
Harbo et al. (2012) conducted a review in Multiple sclerosis. Genetic risk factors was evaluated. Recent progress in genetic studies of multiple sclerosis has identified a growing list of genetic risk factors, with hopes of translating this knowledge into personalized treatment options.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: